We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. According to findings in a recently published study, the ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
The baseline study population consisted of 75 chronic LBP patients (87% women) with M1 in the lumbar spine. During follow-up, 11 patients were lost as dropouts: seven due to lack of clinical data and ...
August 20, 2024 — Among patients undergoing lumbar spinal fusion, the presence of Modic changes is associated with differences in microbial diversity and metabolites in the lumbar cartilaginous ...
London, UK, 07 March 2024 – Persica Pharmaceuticals Ltd, a privately held, clinical stage pharmaceutical company developing an antibiotic formulation for intradiscal injection to treat Chronic Low ...
Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel, non-opioid intradiscal injection for the treatment of chronic Low Back Pain The PP353 clinical trial met the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results